Ron Celeste, CEO of ThinSpring, Will Present "One Version of the Truth: Operating Globally With Structured Content"
Ron Celeste, the CEO of ThinSpring, will present an important topic: "One Version of the Truth: Operating Globally With Structured Content" at The RAPS New York/New Jersey Chapter Meeting on June 7, 2007 at The Inn at Somerset Hills in Basking Ridge, NJ.
Basking Ridge, NJ (PRWEB) May 31, 2007 -- Ron Celeste, the CEO of ThinSpring, a leading provider of XML-based solutions such as XML Sage™, SPL Server™, and the United States Food and Drug Administration's (FDA) Electronic Labeling Information Processing System (ELIPS), will present an important topic: "One Version of the Truth: Operating Globally With Structured Content" at RAPS New York/New Jersey Chapter Meeting on June 7, 2007 at The Inn at Somerset Hills in Basking Ridge, NJ.
Mr. Celeste will illustrate how constant growth in the medical products industries has brought forth new informatics models that bridge a variety of biological and medical information operations. By defining meaning within the product data and focusing on the semantics of information, the knowledge to find cures and deliver them safely will be more readily available to researchers and manufacturers.
Mr. Celeste will discuss what it takes to manage medical product labeling information in a structured content based operating environment. You will learn much more than a standard review of the submissions process. Mr. Celeste will take you through all of the labeling information touch points from every phase of the product development lifecycle. "By encoding these touch points in XML," Mr. Celeste said, "we can accelerate time-to-market, increase quality, and heighten the efficiency of safety metrics." Other discussions of XML and the semantic Web will include emerging standards, improving collaboration, adopting innovation, and succeeding with research & development.
Ron Celeste, president of ThinSpring, has worked with life sciences companies to define and implement leading-edge technology solutions for more than 19 years. His experience spans the entire medical products lifecycle from clinical through regulatory submission and commercialization. Mr. Celeste leads efforts to bring change resulting in tangible cost and time-to-market improvements. He has led successful projects in areas such as electronic document management, chemical and manufacturing control compliance, electronic data capture and electronic submissions. Celeste has held senior management positions with Baxter Healthcare International, C.R. Bard Inc, and Maple Leaf Foods USA. He holds a degree in Engineering from the United States Military Academy at West Point.
RAPS is the largest and most well-known international professional society for healthcare regulatory affairs professionals. Local chapters of RAPS, such as the New Jersey-New York Chapter, give regulatory affairs professionals an opportunity to network with colleagues and share experiences on a local level. As the trends towards globalization continue in the years ahead, the benefits of local networking organizations such as RAPS NJ/NY will make pharmaceutical manufacturing companies better prepared to adjust to the challenges of an expanding world-wide market, through creativity and collaboration, and develop a sense of global awareness and harmonization.
For more information go to the ThinSpring website, contact John McGraw at (302) 478-8399, or go see Ron Celeste present "One Version of the Truth: Operating Globally With Structured Content" at the RAPS New York/New Jersey Chapter Meeting on June 7, 2007 at The Inn at Somerset Hills in Basking Ridge, NJ. We hope to see you there.
About ThinSpring:
ThinSpring, founded by former pharmaceutical and medical device professionals, specializes in XML web-based solutions, integration and data conversion. ThinSpring has used its industry expertise to develop a dynamic XML engine, MatriXML™. This patented XML technology is the basis for all ThinSpring solutions including XML Sage, SPL Server, PIM Server, and eCTD Server. ThinSpring's solutions have gained acceptance as an essential, collaborative application-development platform for FDA regulated companies. ThinSpring's core team manages technology and regulatory consulting divisions that support its clients' operations throughout the United States, Europe, Asia and South America. ThinSpring headquarters is in Bridgewater, New Jersey, with offices in California and North Carolina. More information about ThinSpring and ThinSpring's solutions can be found on their website at: http://www.ThinSpring.com.
###
|
